This training will provide background information on the consequences of substances commonly used by consumers and will introduce participants to the epidemiology and prevalence, and neurobiology of co-occurring disorders. Participants will also learn about screening, assessment and diagnosis of co- occurring disorders, and how to develop behavioral intervention strategies for those with co-occurring substance use and mental health disorders and chronic medical conditions that frequently co-occur with SU and MH issues. The training will also cover treatment considerations, planning, and an overview of EBP interventions, including DDMI, DDCBT, Medication Assisted Treatments, and integrated behavioral health interventions. 

At the conclusion of the COD 101 training session, participants should be able to:

1.    Describe at least three (3) mental health and medical consequences of substance use

2.    Describe how to use MI to engage consumers in a conversation about health behaviors that emphasize change in the context of cultural values

3.    List at least two (2) integrated treatment interventions that can help address the unique needs of consumers with co-occurring disorders
4.    Describe two chronic medical conditions that often co-occur with substance use and mental health issues
5.    Describe three factors that increase risk for development of substance use, mental health, and physical health disorders
6.    Describe how the neurotransmitter dopamine works in the brain and how it
is affected by substance use